Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Osteosarcoma × Zoledronic Acid × Clear all

Phase

Status

Recruiting 3 Completed 2 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Prostatic Neoplasms 1 Osteosarcoma 1 Breast Neoplasms 1 Breast Cancer Metastatic 1

Interventions

X-Rays 4 Phantoms, Imaging 4 Nuclear Medicine Department, Hospital 4 Magnetic Resonance Spectroscopy 4 pembrolizumab 3 Specimen Handling 3 Nivolumab 3 Cyclophosphamide 3 Biopsy 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 regorafenib 2 olaparib 2 larotrectinib 2 ivosidenib 2 ensartinib 2 Etoposide 2 tocilizumab 1 tazemetostat 1 poly ICLC 1 palbociclib 1 naxitamab 1 mifamurtide 1 humanized 3F8 anti-GD2 monoclonal antibody 1 fludarabine phosphate 1 fludarabine 1 flt3 ligand protein 1 etoposide phosphate 1 erdafitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00470223 2025-06-08

OS2006

UNICANCER

Phase 3 Active not recruiting

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡